PVP Ventures Ltd
NSE: PVP BSE: 517556Infra
Incorporated in 1991, PVP Ventures Ltd develops urban infrastructure and investments in various ventures[1]
₹26.9
52W: ₹18.3 — ₹39.9
PE 569 · Book ₹7.96 · +238% vs bookMarket Cap₹700 Cr
Stock P/E569Price to Earnings
ROCE1.99%Return on Capital
ROE1.32%Return on Equity
Div. Yield0%Face Value ₹10
Strengths
- +Company's working capital requirements have reduced from 10,875 days to 146 days
Weaknesses
- −Company has low interest coverage ratio.
- −The company has delivered a poor sales growth of -10.3% over past five years.
- −Earnings include an other income of Rs.5.98 Cr.
Shareholding Pattern
Promoters61.3%
FIIs0.5%
DIIs0%
Public38.2%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 61.4% | 61.4% | 61.34%▼0.1 | 61.34% | 61.34% | 61.3%▼0.0 | 61.3% | 61.3% |
| FIIs | 0.97% | 0.02%▼0.9 | 0%▼0.0 | 0.04%▲0.0 | 0.04% | 0.25%▲0.2 | 0.62%▲0.4 | 0.5%▼0.1 |
| DIIs | 0.17% | 0.15%▼0.0 | 0.15% | 0.15% | 0.1%▼0.0 | 0%▼0.1 | 0% | 0% |
| Public | 37.45% | 38.41%▲1.0 | 38.5%▲0.1 | 38.47%▼0.0 | 38.52%▲0.1 | 38.45%▼0.1 | 38.07%▼0.4 | 38.2%▲0.1 |
Financial Statements
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.9 | 9.19 | 5.07 |
| Expenses | 2.7 | 2.88 | 2.23 | 2.8 | 3.11 | 4.26 | 3.97 | 11.1 | 4.4 | 5.7 |
| Operating Profit | -2.7 | -2.88 | -2.23 | -2.8 | -3.11 | -4.26 | -3.97 | 5.8 | 4.79 | -0.63 |
| OPM % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 34.32% | 52.12% | -12.43% |
| Net Profit | -3.81 | -2.79 | 31.31 | 7.69 | -1.39 | -1.73 | -0.08 | -0.7 | 0.78 | -3.97 |
| EPS ₹ | -0.15 | -0.11 | 1.2 | 0.3 | -0.05 | -0.07 | 0 | -0.03 | 0.03 | -0.15 |
AI Insights
Revenue Trend
TTM revenue at ₹31.16Cr, up 84.8% YoY. OPM at 19.22%.
Debt Position
Borrowings at ₹187.66Cr. Debt-to-equity ratio: N/Ax. High leverage — monitor closely.
Institutional Flow
DIIs: 0% (-0.18pp change). FIIs: 0.5% (-0.49pp change). Promoters hold 61.3%.
Margin & Efficiency
ROCE declining from 3.93% (Mar 2014) to 1.99% (Mar 2025). Working capital days: 145.7.
Valuation
PE 569x with 1.99% ROCE. Price is 238% above book value of ₹7.96. Dividend yield: 0%.
Recent Announcements
- Corrigendum To The Outcome Of The Board Meeting 2d - Corrigendum: Dr. Neeraja Nagarajan appointed Additional Director and COO from 1 July 2026.
- Announcement under Regulation 30 (LODR)-Change in Directorate 2d - Board approved name change to Evervie Health Limited, appointed COO/CFO and three independent directors, and plans international holding company.
- General Updates 2d - Board approved name change to Evervie Health, new directors, CFO/COO appointments, and international holding company plan.
- Board Meeting Outcome for Outcome Of The Board Meeting 2d - Board approved name change to Evervie Health, appointed three independent directors, COO, CFO, and plans international holding company.
- Intimation Of Record Date For Repayment Of The Interest For The Ncds. 13 May - Record date set for NCD interest payment on 19 May 2026; interest payable 20 May 2026.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse